Results from the company’s Phase I trial found its prodrug, SPT-300, was well tolerated, opening the doors to a Phase IIb trial ...

Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the ...

(NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) (“Greenbrook”, and together with Neuronetics, the “Combined Company”) today announced that they have successfully completed the ...

The wish to die is usually transient, or at least time-limited and reversible. Having a support system with an explicit plan ...

“Major depressive disorder” is another name for clinical ... It can take time to find a treatment plan that works, but many people find that their symptoms respond well to a combination ...

Knowing and understanding the differences between sadness and depression can help a person recognize when to seek treatment ... Depression is a mood disorder that has an overpowering effect ...

1 Departamento de Nutrición y Bioquímica, Pontificia Universidad Javeriana, Bogotá, Colombia 2 Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia ...

was associated with a greater reduction in symptoms of major depressive disorder (MDD) than either treatment alone, a new study showed. Researchers conducted a double-blind, sham-controlled ...

unveiled a major five-year strategic action deal between the two countries at the G20 Summit in Brazil. The announcement came after the two leaders met on the sidelines of the summit on November 19.

forests to distinguish patients with major depressive disorder (MDD) from those with bipolar disorder (BD). This distinction, critical for appropriate treatment, remains challenging due to overlapping ...

Many types of light therapy are available to treat several conditions, including sleep disorders and types of depression. Light therapy primarily treats major ... handle the treatment and the ...